Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Adding UFUR to Non-small-cell Lung Cancer Patients Treated With Iressa

NCT01037998 is registered in ClinicalTrials.gov with Taipei Veterans General Hospital, Taiwan as lead sponsor.

NCT NCT01037998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01037998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Adding UFUR to Non-small-cell Lung Cancer Patients Treated With Iressa
Lead sponsor
Taipei Veterans General Hospital, Taiwan
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2005
Completion date
December 31, 2009
Enrollment
115 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small-cell lung cancer